Mortality is the highest during the infantile phase (ranging from 41% to 70% of infants with ENPP1 Deficiency) and occurs predominantly in the first 6 months of life [3,4]. Here, ENPP1 is linked to hyperinsulinemic hypoglycemia, familial, 4.